Related Funds
Fund Name | Location |
A-Z Beteiligungen | Cologne, Germany, Nordrhein-Westfalen |
Aquacopia Venture Partners | New York, New York, United States |
Dundon Capital Partners | Dallas, Texas, United States |
Emergic Ventures | India, Maharashtra, Mumbai |
Fierce Founders Accelerator | - |
Folens | - |
Infront Sports & Media | Switzerland, Zug, Zug |
J. Hunt Holdings | United States, Vienna, Virginia |
JSM Capital | British Columbia, Canada, Vancouver |
Kaufman Financial Group | Connecticut, Farmington, United States |
LORE Associates | Pennsylvania, United States, Wayne |
NAC | Japan, Tokyo |
PNC Business Credit | Haywards Heath, United Kingdom, West Sussex |
Relational Investors LLC. | California, San Diego, United States |
SourceSquared Management | Massachusetts, United States, Woburn |
Stonehenge Growth Equity | Florida, Tampa, United States |
Three Fish Capital | California, San Francisco, United States |
WRAP | Cherwell, England, United Kingdom |
Zing Capital | United States, Vancouver, Washington |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Celldom, Inc | 01 Jan 2021 | Durham, North Carolina, United States | |||
Primmune Therapeutics | $27M | 27 Oct 2020 | San Diego, California, United States | ||
Primmune Therapeutics | $7M | 02 Mar 2020 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Celldom, Inc | 01 Jan 2021 | Durham, North Carolina, United States | |||
Primmune Therapeutics | $27M | 27 Oct 2020 | San Diego, California, United States | ||
Primmune Therapeutics | $7M | 02 Mar 2020 | San Diego, California, United States |